ANGPT2 produced in the BM microenvironment may contribute to the development of MM angiogenesis, and this molecule may be further useful as both a biomarker of angiogenesis and a potential therapeutic target (11). The gene discussed is ANGPT2; the disease is Miyoshi myopathy.